NFKB1 and inflammatory bowel disease: Lancemaside A; atractylenolide IIIa; berberine; costunolide; liriodendrin and notoginsenoside R1 may all decrease IL-1β, IL-6 and TNF-α expression by repressing NF-κB signal transducer in IBD mice or rats (Joh et al.